Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Titel:
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Auteur:
Farooqui, Mohammed Z H Valdez, Janet Martyr, Sabrina Aue, Georg Saba, Nakhle Niemann, Carsten U Herman, Sarah E M Tian, Xin Marti, Gerald Soto, Susan Hughes, Thomas E Jones, Jade Lipsky, Andrew Pittaluga, Stefania Stetler-Stevenson, Maryalice Yuan, Constance Lee, Yuh Shan Pedersen, Lone B Geisler, Christian H Calvo, Katherine R Arthur, Diane C Maric, Irina Childs, Richard Young, Neal S Wiestner, Adrian